New developments in pharmacotherapy of pediatric anxiety disorders

References

• Costello EJ, Angold A. Epidemiology, Anxiety Disorders in Children and Adolescents. March JS (Ed.), Guilford Press, New York, NY, USA, 109–124 (1995).
   Google Scholar
• Giaconia RM, Reinherz HZ, Silverman AB, Pakiz B, Frost AK, Cohen E. Traumas and posttraumatic stress disorder in a community population of older adolescents. jAm Acad. Child Adolesc. Psychiatry 34,1369–1380 (1995).
   PubMed Web of Science ®Google Scholar
• Hayward C, Killen JD, Taylor CB. Panic attacks in young adolescents. Am J.Psychiatry 146,1061–1062 (1989).
   Google Scholar
• Bell-Dolan DJ, Last CG, Strauss CC. Symptoms of anxiety disorders in normal children. jAm. Acad. Child Adolesc.
   Google Scholar
• Ialongo N, Edelsohn GW-LL, Crockett LKS. The significance of self-reported anxious symptoms in first grade children. J. Child Psycho'. Psychiatry22, 441–445 (1995).
   Google Scholar
• Last CG, Hansen C, Franco N. Anxious children in adulthood: a prospective study of adjustment. jAm. Acad. Child Adolesc. Bychiatry36, 645–652 (1997).
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual ofMental Div-Jr/err. (Fourth Ed). American Psychiatric Press, Washington, DC, USA (1994).
   Google Scholar
• Lipsitz JD, Martin LY, Mannuza S, Chapman TF, Liebowitz MR, Klein DE Childhood separation anxiety disorder in patients with adult anxiety disorders. Am. J. Bychiatry151, 927–929 (1994).
   PubMed Web of Science ®Google Scholar
• March JS. Cognitive-behavioral psychotherapy for children and adolescents with OCD: a review and recommendations for treatment. jAm. Acad. Child Adolesc. Bychiatry34, 7–18 (1995).
   PubMedGoogle Scholar
• March JS, Amaya-Jackson L, Murray MC, Schulte A. Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor. J. Am. Acad. Child Adolesc. Ptychiatry37, 585–593 (1998).
   PubMed Web of Science ®Google Scholar
• Barrett PM, Duffy AL, Dadds MR, Rapee RM. Cognitive-behavioral treatment of anxiety disorders in children: long-term (6-year) follow-up. J. Consult. Clin. Psycho" 69,135–141 (2001) .
   Google Scholar
• Toren P, Rosental B, Eldar S et al. Case series: brief parent-child group therapy for childhood anxiety disorders using a manual-based cognitive-behavioral technique. jAm. Acad. Child Adolesc. Psychiatry39, 1309–1312 (2001).
   Google Scholar
• Bernstein GA, Borschardt CM, Perwein AR et al Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J. Am. Acad. Child Adolesc. Psychiatry 39, 276–283 (2000).
   PubMed Web of Science ®Google Scholar
• Allen AJ, Leonard HL. Current knowledge of medications for the treatment of childhood anxiety disorders. jAm. Acad. Child Adolesc. Psychiatry 34,976–986 (1995).
   Google Scholar
• Mancini C, Van Ameringen M, Oakman JM, Farvolden P Serotonergic agents in the treatment of social phobia in children and adolescents: a case series. Depress. Anxiety 10,33–39 (1999).
   PubMed Web of Science ®Google Scholar
• Domon SE, Andersen MS. Nefazodone for PTSD (letter). jAm. Acad. Child Adolesc. Psychiatry 39,942–943 (2000).
   PubMedGoogle Scholar
• Harmon RJ, Riggs PD. Clonidine for posttraumatic stress disorder in preschool children. jAm. Acad. Child Adolesc. Psychiatry35, 1247–1249 (1996).
   PubMed Web of Science ®Google Scholar
• Famularo R, Kinscherff R, Fenton T Propranolol treatment for childhood post-traumatic stress disorder, acute type. Am. J. Dis. Chilc1142, 1244–1247 (1988).
   Google Scholar
• Leonard HL, March J, Rickler KC, Allen AJ. Pharmacology of the selective serotonin re-uptake inhibitors in children and adolescents. jAm. Acad. Child Adolesc. P9rhiatry36, 725–736 (1997). Summarizes information on metabolism and side effects in children.
   Google Scholar
• Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. jAm. Acad. Child Adolesc Psychiatry33, 1000–1006 (1994).
   PubMed Web of Science ®Google Scholar
• Dummit ES, Klein RG, Tancer NK, Asche B, Martin J, Fairbanks J. Systematic Assessment of 50 children with selective mutism. Am Psychiatry36, 653–660 (1997).
   Google Scholar
• Riddle MA, Scahill L, King RA et al. Double-blind, cross-over trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. j Am. Acad. Child Adolesc. P9rhiatry31, 1062–1069 (1992).
   Google Scholar
• Geller DA, Hoog SL, Heiligenstein JH et al Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial. jAm. Acad. Child Adolesc. Psychiaby 40,773–779 (2001).
   PubMed Web of Science ®Google Scholar
• Birmaher B, Waterman GS, Ryan N et al Fluoxetine for childhood anxiety disorders. .1. Am Acad. Child Adolesc. Psychiatry 33, 993–999 (1994).
   Google Scholar
• March JS, Biederman J, Wolkow R et al. Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JA/V/4 280,1752–1756 (1998) .
   Google Scholar
• Cook EH, Wagner KD, March JS, Biederman J, Landau PWR, Messig M. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. jAm. Acad. Child Adolesc. P9rhiatry 40, 1175–1181 (2001).
   Google Scholar
• Rynn MA, Siqueland L, Rickels K. Placebo- controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am. j Psychiatry 158, 2008–2014 (2001).
   Google Scholar
• Compton SN, Grant PJ, Chrisman AK, Gammon PJ, Brown VL, March JS. Sertraline in children and adolescents with social anxiety disorder: an open trial.' Am. Acad. Child Adolesc Psychiatry40, 564–571 (2001).
   PubMed Web of Science ®Google Scholar
• Walkup JT, Labellarte M, Riddle M et al Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl Med 344,1279–1285 ( 2001).
   PubMed Web of Science ®Google Scholar
• •This article is of interest because of the strong evidence of efficacy in children with mixed anxiety disorders that would be commonly seen in pediatric practice and primary care.
   Google Scholar
• Walkup JT, Reeve E, Yaryuya-Tobias J et al Fluvoxamine for childhood OCD: long-term treatment. Proceedings of the 45th Annual Meeting of the American Academy of Child and Adolescent P9rhiatry, Anaheim, CA, USA, NR-69 (1998).
   Google Scholar
• Riddle MA, Reeve EA, Yaryura-Tobias JA et al Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. j Am. Acad. Child Adolesc. fiychMtry40, 222–229 (2001).
   PubMed Web of Science ®Google Scholar
• Rosenberg DR, Stewart CM, Fitzgerald KD, Tawile V, Carroll E Paroxetine open-label treatment of pediatric out-patients with obsessive-compulsive disorder. jAm Acad Child Adolesc Bychiatzy38,1180–1185 (1999).
   PubMed Web of Science ®Google Scholar
• Rosenberg DR, MacMaster FP, Keshavan MS et al Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. jAm. Acad. Child Adolesc. Psychiatry39, 1096–1103 (2000).
   PubMed Web of Science ®Google Scholar
• •Notable for the correspondence between clinical improvement and neurophysiological changes.
   Google Scholar
• Thomsen PH, Ebbesen C, Persson C. Long- term experience with citaloprarn in the treatment of adolescent OCD. jAm Acad. Child Adolesc. Psychiatry40, 895–902 (2001).
   PubMed Web of Science ®Google Scholar
• Seedat S, Lockhat R, Kaminer D, Zungu- Dirwayi N, Stein DJ. An open trial of citalopram in adolescents with post-traumatic stress disorder. Int. Clin Psychopharmacol 16,21–25 (2001).
   Google Scholar
• Emslie G, Rush A, Weinberg W et al A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Azrh. Gen. Psychiatry54, 1031–1037 (1997).
   PubMed Web of Science ®Google Scholar
• Keller M, Ryan N, Strober M et al Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. jAm. Acad. Child Adolesc. Psychiatry 40,762–772 (2001).
   PubMed Web of Science ®Google Scholar
• Alderman J, Wolkow R, Chung M, Johnston Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: pharmacokinetics, tolerability and efficacy. jAm. Acad. Child Adolesc BychMtry37, 386–394 (1998).
   PubMed Web of Science ®Google Scholar
• Riddle MA, King RA, Hardin MT et al Behavioral side effects of fluoxetine in children and adolescents. j Child Adolesc. P9rhopharm. 1,193-198 (1991).
   Google Scholar
• Hoehn-Saric R, Lipsey JR, McLeod DR. Apathy and indifference in patients on fluvoxamine and fluoxetine. j Clin. P9rhophalmacol 10,343–345 (1990).
   Google Scholar
• Hoehn-Saric R, Harris GJ, Pearlson GD, Cox CS, Machlin SR, Camargo EE. A fluoxetine-induced frontal lobe syndrome in an obsessive-compulsive patient. J. Clin. PFiziatry52, 131–133 (1991).
   Google Scholar
• Garland EJ, Baerg AE. Amotivational syndrome associated with selective serotonin re-uptake inhibitors in children and adolescents. j Child Adolesc. P9rhopharm. 11,181-186 (2001).
   Google Scholar
• Di Mascio M, Di Giovanni G, Di Matte° V, Prisco S, Esposito E. Selective serotonin re-uptake inhibitors reduce the spontaneous activity of dopaminergic neurons in the ventral tegmental area. Brain Res. Bull 46,547–554 (1998).
   Google Scholar
• Pies R. Must we now consider SRIs neuroleptics?j Clin. Psychiatry 17,443–445 (1997).
   Google Scholar
• Madhusoodanan S, Brenner R. Reversible choreiform dyskinesia and extrapyramidal symptoms associated with sertraline therapy. .1. Clin. Psychopharmacol 17,138–139 (1997).
   Google Scholar
• Gerber PE, Lynd L. Selective serotonin-re- uptake inhibitor induced movement disorders. Ann. Pharmacother. 32,692–698 (1998).
   PubMed Web of Science ®Google Scholar
• Jones-Fearing KB. SSRI and EPS with fluoxetine. jAm. Acad. Child Adolesc. PFiziatry 35,1107–1108 (1996).
   PubMedGoogle Scholar
• Lenti C. Movement disorders associated with fluvoxamine. jAm. Acad. Child Adolesc PFiziatry 38,942–943 (1999).
   PubMedGoogle Scholar
• Bates G, Khin-Maung-Zaw F. Movement disorders with fluoxetine. J. Am. Acad. Child Adolesc. Psychiatry 37,14–15 (1998).
   PubMedGoogle Scholar
• Bradley SJ. Fluoxetine and memory impairment. jAm. Acad. Child Adolesc. PFiziatry 32,1078–1079 (1993).
   PubMedGoogle Scholar
• Reynolds CR, Richmond BO. What I think and feel: a revised measure of children's manifest anxiety. j Abn. Child P9rhol. 6,787-792 (1978).
   Google Scholar
• March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The multidimensional anxiety scale for children (MASC): factor structure, reliability and validity. J. Am Acad. Child Adolesc. Psychiatry36, 554–565 (1997).
   Google Scholar
• Hamilton M. The assessment of anxiety states by rating. BE J. Med. Bychol. 32,50-55 (1959).
   Google Scholar
• Kutcher S, Mackenzie S. Successful clonazepam treatment of adolescents with panic disorder. J. Gun. P9rhopharmacol 8, 299–301 (1988).
   Google Scholar
• Amsterdam JD. Breast enlargement during chronic antidepressant therapy. J. Affi,ct. Disolrl 46, 151–156 (1997).
   PubMedGoogle Scholar